TY - STD TI - National Comprehensive Cancer Network (2017). Stage IV Breast Cancer Guidelines Version 1.0. https://www.nccn.org/patients/guidelines/stage_iv_breast/index.html#. Accessed 3/27/17. UR - https://www.nccn.org/patients/guidelines/stage_iv_breast/index.html ID - ref1 ER - TY - JOUR AU - Smith, I. PY - 2006 DA - 2006// TI - Goals of treatment for patients with metastatic breast Cancer JO - Seminars in Oncology VL - 33 UR - https://doi.org/10.1053/j.seminoncol.2005.07.030. DO - 10.1053/j.seminoncol.2005.07.030. ID - Smith2006 ER - TY - JOUR PY - 2009 DA - 2009// TI - Guidance for industry on patient-reported outcome measures: Use in medical product development to support labeling claims; availability JO - Federal Register VL - 74 ID - ref3 ER - TY - JOUR AU - Zagadailov, E. AU - Fine, M. AU - Shields, A. PY - 2013 DA - 2013// TI - Patient-reported outcomes are changing the landscape in oncology care: Challenges and opportunities for payers JO - American Health & Drug Benefits VL - 6 ID - Zagadailov2013 ER - TY - STD TI - US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, & Center for Biologics Evaluation and Research (2015). Guidance for Industry: Clinical Trial Endpoints for the Approval of Non-Small Cell Lung Cancer Drugs and Biologics. ID - ref5 ER - TY - JOUR AU - Kluetz, P. G. AU - Slagle, A. AU - Papadopoulos, E. J. AU - Johnson, L. L. AU - Donoghue, M. AU - Kwitkowski, V. E. PY - 2016 DA - 2016// TI - Focusing on Core patient-reported outcomes in Cancer clinical trials: Symptomatic adverse events, physical function, and disease-related symptoms JO - Clinical Cancer Research VL - 22 UR - https://doi.org/10.1158/1078-0432.ccr-15-2035 DO - 10.1158/1078-0432.ccr-15-2035 ID - Kluetz2016 ER - TY - JOUR AU - Garcia, S. F. AU - Rosenbloom, S. K. AU - Beaumont, J. L. AU - Merkel, D. AU - Roenn, J. H. AU - Rao, D. PY - 2012 DA - 2012// TI - Priority symptoms in advanced breast cancer: Development and initial validation of the National Comprehensive Cancer Network-Functional Assessment of Cancer therapy-breast Cancer symptom index (NFBSI-16) JO - Value Health VL - 15 UR - https://doi.org/10.1016/j.jval.2011.08.1739 DO - 10.1016/j.jval.2011.08.1739 ID - Garcia2012 ER - TY - JOUR AU - Lewis, S. AU - Yee, J. AU - Kilbreath, S. AU - Willis, K. PY - 2015 DA - 2015// TI - A qualitative study of women's experiences of healthcare, treatment and support for metastatic breast cancer JO - Breast VL - 24 UR - https://doi.org/10.1016/j.breast.2015.02.025 DO - 10.1016/j.breast.2015.02.025 ID - Lewis2015 ER - TY - JOUR AU - Mosher, C. E. AU - Johnson, C. AU - Dickler, M. AU - Norton, L. AU - Massie, M. J. AU - DuHamel, K. PY - 2013 DA - 2013// TI - Living with metastatic breast cancer: A qualitative analysis of physical, psychological, and social sequelae JO - The Breast Journal VL - 19 UR - https://doi.org/10.1111/tbj.12107 DO - 10.1111/tbj.12107 ID - Mosher2013 ER - TY - JOUR AU - Turner, J. AU - Kelly, B. AU - Swanson, C. AU - Allison, R. AU - Wetzig, N. PY - 2005 DA - 2005// TI - Psychosocial impact of newly diagnosed advanced breast cancer JO - Psychooncology VL - 14 UR - https://doi.org/10.1002/pon.856 DO - 10.1002/pon.856 ID - Turner2005 ER - TY - JOUR AU - Krohe, M. AU - Hao, Y. AU - Lamoureux, R. E. AU - Galipeau, N. AU - Globe, D. AU - Foley, C. PY - 2016 DA - 2016// TI - Patient-reported outcomes in metastatic breast Cancer: A review of industry-sponsored clinical trials JO - Breast Cancer (Auckl) VL - 10 UR - https://doi.org/10.4137/bcbcr.s39385 DO - 10.4137/bcbcr.s39385 ID - Krohe2016 ER - TY - JOUR AU - Turner-Bowker, D. M. AU - Lamoureux, R. E. AU - Stokes, J. AU - Litcher-Kelly, L. AU - Galipeau, N. AU - Yaworsky, A. PY - 2018 DA - 2018// TI - Informing a priori sample size estimation in qualitative concept elicitation interview studies for clinical outcome assessment instrument development JO - Value Health VL - 21 UR - https://doi.org/10.1016/j.jval.2017.11.014 DO - 10.1016/j.jval.2017.11.014 ID - Turner-Bowker2018 ER - TY - JOUR AU - Patrick, D. L. AU - Burke, L. B. AU - Gwaltney, C. J. AU - Leidy, N. K. AU - Martin, M. L. AU - Molsen, E. PY - 2011 DA - 2011// TI - Content validity-establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: Part 1-eliciting concepts for a new PRO instrument JO - Value Health VL - 14 UR - https://doi.org/10.1016/j.jval.2011.06.014 DO - 10.1016/j.jval.2011.06.014 ID - Patrick2011 ER - TY - BOOK AU - Friese, S. PY - 2013 DA - 2013// TI - ATLAS.ti 7 User Guide and Reference PB - ATLAS.ti Scientific Software Development GmbH CY - Berlin ID - Friese2013 ER - TY - BOOK AU - Lewins, A. AU - Silver, C. PY - 2007 DA - 2007// TI - Using software in qualitative research: A step-by-step guide PB - Sage Publications CY - London UR - https://doi.org/10.4135/9780857025012 DO - 10.4135/9780857025012 ID - Lewins2007 ER - TY - JOUR AU - Lasch, K. E. AU - Hassan, M. AU - Endicott, J. AU - Piault-Luis, E. C. AU - Locklear, J. AU - Fitz-Randolph, M. PY - 2012 DA - 2012// TI - Development and content validity of a patient reported outcomes measure to assess symptoms of major depressive disorder JO - BMC Psychiatry VL - 12 UR - https://doi.org/10.1186/1471-244X-12-34 DO - 10.1186/1471-244X-12-34 ID - Lasch2012 ER - TY - CHAP AU - Charmaz, K. ED - Smith, J. A. ED - Harre, R. ED - Langenhove, L. PY - 1995 DA - 1995// TI - Grounded theory BT - Rethinking methods in psychology PB - Sage CY - London UR - https://doi.org/10.4135/9781446221792.n3 DO - 10.4135/9781446221792.n3 ID - Charmaz1995 ER - TY - CHAP AU - Glaser, B. AU - Strauss, A. L. ED - Glaser, B. ED - Strauss, A. L. PY - 1967 DA - 1967// TI - The constant comparative method of qualitative analysis BT - Discovery of grounded theory: Strategies for qualitative research PB - Aldine de Gruyter CY - New York ID - Glaser1967 ER - TY - JOUR AU - Butt, Z. AU - Rosenbloom, S. K. AU - Abernethy, A. P. AU - Beaumont, J. L. AU - Paul, D. AU - Hampton, D. PY - 2008 DA - 2008// TI - Fatigue is the most important symptom for advanced cancer patients who have had chemotherapy JO - Journal of the National Comprehensive Cancer Network VL - 6 UR - https://doi.org/10.6004/jnccn.2008.0036 DO - 10.6004/jnccn.2008.0036 ID - Butt2008 ER - TY - JOUR AU - Siefert, M. L. PY - 2010 DA - 2010// TI - Fatigue, pain, and functional status during outpatient chemotherapy JO - Oncology Nursing Forum VL - 37 UR - https://doi.org/10.1188/10.ONF.114-123 DO - 10.1188/10.ONF.114-123 ID - Siefert2010 ER - TY - JOUR AU - Cleeland, C. S. AU - Sloan, J. A. PY - 2010 DA - 2010// TI - Assessing the Symptoms of Cancer Using Patient-Reported Outcomes (ASCPRO): searching for standards JO - Journal of Pain and Symptom Management VL - 39 UR - https://doi.org/10.1016/j.jpainsymman.2009.05.025 DO - 10.1016/j.jpainsymman.2009.05.025 ID - Cleeland2010 ER - TY - JOUR AU - Rosenberg, S. M. AU - Stanton, A. L. AU - Petrie, K. J. AU - Partridge, A. H. PY - 2015 DA - 2015// TI - Symptoms and symptom attribution among women on endocrine therapy for breast Cancer JO - The Oncologist VL - 20 UR - https://doi.org/10.1634/theoncologist.2015-0007 DO - 10.1634/theoncologist.2015-0007 ID - Rosenberg2015 ER -